706 NOUS-PEV,一种针对患者特异性新抗原的新型个性化基于病毒的先导/增强癌症免疫疗法:1b期研究中首批受试者的中期结果

O. Bechter, J. Martín-Liberal, A. D’Alise, G. Leoni, G. Cotugno, L. Siani, Rosa Vitale, Valentino Ruzza, E. Micarelli, Irene Garzia, T. Faivre, S. Gogov, P. Delaite, S. Colloca, Maria Ambrosio, R. Merone, E. Scarselli, S. Symeonides
{"title":"706 NOUS-PEV,一种针对患者特异性新抗原的新型个性化基于病毒的先导/增强癌症免疫疗法:1b期研究中首批受试者的中期结果","authors":"O. Bechter, J. Martín-Liberal, A. D’Alise, G. Leoni, G. Cotugno, L. Siani, Rosa Vitale, Valentino Ruzza, E. Micarelli, Irene Garzia, T. Faivre, S. Gogov, P. Delaite, S. Colloca, Maria Ambrosio, R. Merone, E. Scarselli, S. Symeonides","doi":"10.1136/jitc-2022-sitc2022.0706","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"706 NOUS-PEV, a novel personalized viral-based prime/boost cancer immunotherapy targeting patient-specific neoantigens: interim results from the first subjects in the phase 1b study\",\"authors\":\"O. Bechter, J. Martín-Liberal, A. D’Alise, G. Leoni, G. Cotugno, L. Siani, Rosa Vitale, Valentino Ruzza, E. Micarelli, Irene Garzia, T. Faivre, S. Gogov, P. Delaite, S. Colloca, Maria Ambrosio, R. Merone, E. Scarselli, S. Symeonides\",\"doi\":\"10.1136/jitc-2022-sitc2022.0706\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":398566,\"journal\":{\"name\":\"Regular and Young Investigator Award Abstracts\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regular and Young Investigator Award Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jitc-2022-sitc2022.0706\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regular and Young Investigator Award Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jitc-2022-sitc2022.0706","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
706 NOUS-PEV, a novel personalized viral-based prime/boost cancer immunotherapy targeting patient-specific neoantigens: interim results from the first subjects in the phase 1b study
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信